rs104894707
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_181882.3(PRX):c.2145T>A(p.Cys715Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,593,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
PRX
NM_181882.3 stop_gained
NM_181882.3 stop_gained
Scores
7
Clinical Significance
Conservation
PhyloP100: -3.48
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-40396207-A-T is Pathogenic according to our data. Variant chr19-40396207-A-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 4792.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-40396207-A-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRX | NM_181882.3 | c.2145T>A | p.Cys715Ter | stop_gained | 7/7 | ENST00000324001.8 | NP_870998.2 | |
PRX | NM_001411127.1 | c.2430T>A | p.Cys810Ter | stop_gained | 7/7 | NP_001398056.1 | ||
PRX | XM_017027047.2 | c.2043T>A | p.Cys681Ter | stop_gained | 4/4 | XP_016882536.1 | ||
PRX | NM_020956.2 | c.*2350T>A | 3_prime_UTR_variant | 6/6 | NP_066007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRX | ENST00000324001.8 | c.2145T>A | p.Cys715Ter | stop_gained | 7/7 | 1 | NM_181882.3 | ENSP00000326018 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 7AN: 133170Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
133170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251342Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135864
GnomAD3 exomes
AF:
AC:
2
AN:
251342
Hom.:
AF XY:
AC XY:
1
AN XY:
135864
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1460188Hom.: 0 Cov.: 37 AF XY: 0.0000151 AC XY: 11AN XY: 726462
GnomAD4 exome
AF:
AC:
30
AN:
1460188
Hom.:
Cov.:
37
AF XY:
AC XY:
11
AN XY:
726462
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000525 AC: 7AN: 133282Hom.: 0 Cov.: 32 AF XY: 0.0000155 AC XY: 1AN XY: 64708
GnomAD4 genome
AF:
AC:
7
AN:
133282
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
64708
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | PRX: PVS1:Strong, PM2, PM3 - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 26, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 12, 2020 | This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 12, 2022 | Nonsense variant predicted to result in protein truncation, as the last 747 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 12112076, 21840889, 20625412, 32085570) - |
Charcot-Marie-Tooth disease type 4F Pathogenic:2Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2002 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Jul 26, 2022 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Charcot-Marie-Tooth disease Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics Laboratory, London Health Sciences Centre | - | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 23, 2019 | The p.C715* variant (also known as c.2145T>A), located in coding exon 4 of the PRX gene, results from a T to A substitution at nucleotide position 2145. This changes the amino acid from a cysteine to a stop codon within coding exon 4. This alteration has been described homozygous in a brother and sister with Charcot-Marie-Tooth disease type 4F with disease onset prior to age 1 year and slow progression of disease. Additionally, unaffected siblings were either heterozygous or negative for the alteration (Takashima H et al. Ann. Neurol., 2002 Jun;51:709-15; Baets J et al. Brain, 2011 Sep;134:2664-76). Premature stop codons are typically deleterious in nature, however, this stop codon occurs at the 3' terminus of PRX, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 747 amino acids of the protein, which accounts for over 50% of the protein. Additional truncating alterations downstream of this alteration have been reported in the literature as disease-causing. In addition, the truncated region is suggested to be responsible for targeting the protein for ubiquitin-mediated proteolysis (Takashima H et al. Ann. Neurol., 2002 Jun;51:709-15). Studies in mice have also shown protein disruption when this C-terminal region is deleted (Sherman DL et al. Wellcome Open Res, 2018 Mar;3:20). As such, this alteration is interpreted as a disease-causing mutation. - |
Charcot-Marie-Tooth disease type 4 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PRX protein in which other variant(s) (p.Arg1070*) have been determined to be pathogenic (PMID: 15197604, 15469949, 16770524, 22847150, 26059842). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 4792). This premature translational stop signal has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 12112076). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs104894707, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Cys715*) in the PRX gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 747 amino acid(s) of the PRX protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at